IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010311 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rumen Filev und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria. Hauptthemen laut MEDLINE: COVID-19, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120 COVID-19 patients, of whom 70 had chronic kidney disease. All the samples were taken at emergency-department (ED) admission. Our goal was to relate the biomarkers to the results of death and acute kidney injury. All the patients underwent chest computer tomography to estimate the severity score (0–5), which was performed at hospital admission. Finally, biomarkers were also evaluated in a healthy control group and in non-COVID-19-CKD patients. IL-6 and SAA were statistically different between the subgroups, i.e., they were significantly increased in patients with COVID-19. Both of the biomarkers (IL-6 and SAA) were independently associated with mortality, AKI and a higher grade of pathological changes in the lung’s parenchyma. Both high baseline levels of IL-6 and SAA on hospital admission were highly correlated with a later ventilatory requirement and mortality, independent of hospital stay. Mortality was found to be significantly higher when the chest CT severity score was 3–4, compared with a severity score of 0–2 (p < 0.0001). Conclusions: at the admission stage, IL-6 and SAA are useful markers for COVID-19 patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria.
- Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.
- Head Biometrics Group, Comac-Medical Ltd., 1404 Sofia, Bulgaria.
- Department of Clinical Laboratory, University Hospital "Alexandrovska", 1431 Sofia, Bulgaria.
- Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Grenoble University Hospital, 38043 Grenoble, France.
- Internal Disease Department, Grenoble Alpes University, 38043 Grenoble, France.
ORCID-Profile: Rumen Filev, Krassimir Kalinov, Julieta Hristova, Lionel Rostaing
Zitieren
APA
Filev, R., Lyubomirova, M., Bogov, B., Kalinov, K., Hristova, J., Svinarov, D., & Rostaing, L. (2023). IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010311
Vancouver
Filev R, Lyubomirova M, Bogov B, Kalinov K, Hristova J, Svinarov D, et al. IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010311
BibTeX
@article{Filev2023,
author = {Filev, Rumen and Lyubomirova, Mila and Bogov, Boris and Kalinov, Krassimir and Hristova, Julieta and Svinarov, Dobrin and Rostaing, Lionel},
title = {IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010311}
}
EUVIMED